318 related articles for article (PubMed ID: 8898356)
1. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
[TBL] [Abstract][Full Text] [Related]
2. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
Spitaler M; Utz I; Hilbe W; Hofmann J; Grunicke HH
Biochem Pharmacol; 1998 Oct; 56(7):861-9. PubMed ID: 9774148
[TBL] [Abstract][Full Text] [Related]
3. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
4. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities.
Loo TW; Clarke DM
J Biol Chem; 1995 Sep; 270(37):21449-52. PubMed ID: 7665554
[TBL] [Abstract][Full Text] [Related]
5. Purification and reconstitution of human P-glycoprotein.
Ambudkar SV; Lelong IH; Zhang J; Cardarelli C
Methods Enzymol; 1998; 292():492-504. PubMed ID: 9711577
[TBL] [Abstract][Full Text] [Related]
6. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation site mutations in the human multidrug transporter modulate its drug-stimulated ATPase activity.
Szabó K; Bakos E; Welker E; Müller M; Goodfellow HR; Higgins CF; Váradi A; Sarkadi B
J Biol Chem; 1997 Sep; 272(37):23165-71. PubMed ID: 9287320
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.
Bakos E; Klein I; Welker E; Szabó K; Müller M; Sarkadi B; Váradi A
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):777-83. PubMed ID: 9169612
[TBL] [Abstract][Full Text] [Related]
10. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein.
Ambudkar SV; Cardarelli CO; Pashinsky I; Stein WD
J Biol Chem; 1997 Aug; 272(34):21160-6. PubMed ID: 9261121
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein substrates and antagonists cluster into two distinct groups.
Scala S; Akhmed N; Rao US; Paull K; Lan LB; Dickstein B; Lee JS; Elgemeie GH; Stein WD; Bates SE
Mol Pharmacol; 1997 Jun; 51(6):1024-33. PubMed ID: 9187269
[TBL] [Abstract][Full Text] [Related]
12. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system.
Hrycyna CA; Ramachandra M; Pastan I; Gottesman MM
Methods Enzymol; 1998; 292():456-73. PubMed ID: 9711574
[No Abstract] [Full Text] [Related]
14. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.
Safa AR; Stern RK; Choi K; Agresti M; Tamai I; Mehta ND; Roninson IB
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7225-9. PubMed ID: 1976255
[TBL] [Abstract][Full Text] [Related]
15. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
[TBL] [Abstract][Full Text] [Related]
16. Drug-stimulated ATPase activity of the human P-glycoprotein.
Scarborough GA
J Bioenerg Biomembr; 1995 Feb; 27(1):37-41. PubMed ID: 7629050
[TBL] [Abstract][Full Text] [Related]
17. Purification and reconstitution of functional human P-glycoprotein.
Ambudkar SV
J Bioenerg Biomembr; 1995 Feb; 27(1):23-9. PubMed ID: 7629047
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins.
Chen G; Durán GE; Steger KA; Lacayo NJ; Jaffrézou JP; Dumontet C; Sikic BI
J Biol Chem; 1997 Feb; 272(9):5974-82. PubMed ID: 9038218
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
[TBL] [Abstract][Full Text] [Related]
20. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.
Ambudkar SV; Lelong IH; Zhang J; Cardarelli CO; Gottesman MM; Pastan I
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8472-6. PubMed ID: 1356264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
